We are live on
!
Find out more
Two Sigma Advisers Portfolio holdings
AUM
$51.4B
1-Year Est. Return
31.07%
This Fund
S&P 500
This Quarter
Est. Return
-3.02%
1 Year Est. Return
+31.07%
3 Year Est. Return
+128.94%
5 Year Est. Return
+161.75%
10 Year Est. Return
+607.04%
AUM
$34.5B
AUM Growth
-$708M
(-2%)
Cap. Flow
+$1.23B
Cap. Flow
% of AUM
3.55%
Top 10 Holdings %
Top 10 Hldgs %
13.77%
Holding
2,852
New
233
Increased
919
Reduced
1,343
Closed
332
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Enphase Energy
ENPH
|
+$342M |
| 2 |
Intel
INTC
|
+$276M |
| 3 |
TSMC
TSM
|
+$237M |
| 4 |
Procter & Gamble
PG
|
+$178M |
| 5 |
JPMorgan Chase
JPM
|
+$170M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Netflix
NFLX
|
+$383M |
| 2 |
Occidental Petroleum
OXY
|
+$321M |
| 3 |
PayPal
PYPL
|
+$316M |
| 4 |
S&P Global
SPGI
|
+$145M |
| 5 |
Datadog
DDOG
|
+$133M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.57% |
| 2 | Healthcare | 17.95% |
| 3 | Financials | 9.89% |
| 4 | Industrials | 9.61% |
| 5 | Consumer Discretionary | 7.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1651
Consolidated Water Co
CWCO
$472M
| $781K | ﹤0.01% |
50,800
-2,600
| -5% | -$41K |
|
|
LTC
1652
LTC Properties
LTC
$2.13B
| $779K | ﹤0.01% |
+20,800
| New | +$866K |
|
1653
Weibo
WB
$1.97B
| $778K | ﹤0.01% |
45,488
-62,700
| -58% | -$1.21M |
|
1654
PCB Bancorp
PCB
$394M
| $777K | ﹤0.01% |
43,000
-74,300
| -63% | -$1.41M |
|
1655
Invesco S&P 500 High Dividend Low Volatility ETF
SPHD
$3.41B
| $774K | ﹤0.01% |
+19,800
| New | +$873K |
|
1656
Daktronics
DAKT
$946M
| $769K | ﹤0.01% |
283,900
-20,000
| -7% | -$68.8K |
|
1657
BioXcel Therapeutics
BTAI
$24.8M
| $765K | ﹤0.01% |
4,044
-2,156
| -35% | -$501K |
|
1658
CytomX Therapeutics
CTMX
$690M
| $765K | ﹤0.01% |
527,400
+140,400
| +36% | +$216K |
|
1659
Beyond Air
XAIR
$3.97M
| $764K | ﹤0.01% |
257
-168
| -40% | -$630K |
|
1660
SoundThinking
SSTI
$108M
| $762K | ﹤0.01% |
26,500
-7,400
| -22% | -$232K |
|
1661
International Seaways
INSW
$4.68B
| $761K | ﹤0.01% |
+21,649
| New | +$599K |
|
1662
Alerus Financial
ALRS
$828M
| $760K | ﹤0.01% |
34,400
-800
| -2% | -$18.9K |
|
1663
West Bancorporation
WTBA
$476M
| $760K | ﹤0.01% |
36,500
+19,900
| +120% | +$480K |
|
|
CMBT
1664
CMB.TECH NV
CMBT
$4.52B
| $756K | ﹤0.01% |
+49,148
| New | +$748K |
|
|
AMED
1665
DELISTED
Amedisys
AMED
| $755K | ﹤0.01% |
7,800
-13,000
| -63% | -$1.55M |
|
1666
Omeros
OMER
$845M
| $754K | ﹤0.01% |
239,500
-136,300
| -36% | -$632K |
|
1667
Accel Entertainment
ACEL
$1B
| $753K | ﹤0.01% |
96,400
-71,700
| -43% | -$729K |
|
1668
Vitamin Cottage Natural Grocers
NGVC
$760M
| $753K | ﹤0.01% |
69,800
+35,300
| +102% | +$524K |
|
1669
Element Solutions
ESI
$8.48B
| $752K | ﹤0.01% |
+46,200
| New | +$862K |
|
1670
First Trust NYSE Arca Biotechnology Index Fund
FBT
$2.84B
| $752K | ﹤0.01% |
+5,700
| New | +$800K |
|
1671
Monarch Casino & Resort
MCRI
$2.2B
| $747K | ﹤0.01% |
13,300
-2,700
| -17% | -$165K |
|
1672
RBB Bancorp
RBB
$448M
| $746K | ﹤0.01% |
35,900
-22,600
| -39% | -$491K |
|
1673
Enact Holdings
ACT
$6.75B
| $745K | ﹤0.01% |
+33,600
| New | +$806K |
|
1674
Northeast Bank
NBN
$1.04B
| $744K | ﹤0.01% |
20,300
-8,700
| -30% | -$342K |
|
1675
Cogent Biosciences
COGT
$6.76B
| $743K | ﹤0.01% |
+49,790
| New | +$682K |
|
Similar funds
CWM
VRS
FAF
BGIM
CIM
PPFA
Two Sigma Advisers's Q3 2022 Portfolio in Review
As of Q3 2022, Two Sigma Advisers held 2,852 positions worth $34.5B, down 2% from $35.3B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Two Sigma Advisers deployed $1.23B of net new capital in Q3 2022, opening 233 new positions and adding to 919 existing holdings. Its largest new stake was State Street SPDR S&P Biotech ETF: 1,329,800 shares worth $105M.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 24% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Netflix, an estimated $383M trimmed.
- Two Sigma Advisers's largest Q3 2022 buy was State Street SPDR S&P Biotech ETF: 1,329,800 shares worth $105M.
- Two Sigma Advisers added most to Enphase Energy in Q3 2022, an estimated $342M increase.
- Two Sigma Advisers's biggest Q3 2022 reduction was Netflix, cutting an estimated $383M.
- Two Sigma Advisers fully exited S&P Global in Q3 2022, selling an estimated $145M.
- Two Sigma Advisers's ten largest holdings make up 14% of its $34.5B portfolio in Q3 2022.
- Two Sigma Advisers opened 233 new positions and closed 332 in Q3 2022.
- Two Sigma Advisers's portfolio value fell 2% quarter-over-quarter to $34.5B.
Based on Two Sigma Advisers's 13F filing for Q3 2022, filed 14 Nov 2022.